156 related articles for article (PubMed ID: 30192132)
1. Hypoxia-Activated Anticancer Prodrug for Bioimaging, Tracking Drug Release, and Anticancer Application.
Liu W; Liu H; Peng X; Zhou G; Liu D; Li S; Zhang J; Wang S
Bioconjug Chem; 2018 Oct; 29(10):3332-3343. PubMed ID: 30192132
[TBL] [Abstract][Full Text] [Related]
2. Hypoxia-Activated and Indomethacin-Mediated Theranostic Prodrug Releasing Drug On-Demand for Tumor Imaging and Therapy.
Peng X; Gao J; Yuan Y; Liu H; Lei W; Li S; Zhang J; Wang S
Bioconjug Chem; 2019 Nov; 30(11):2828-2843. PubMed ID: 31592652
[TBL] [Abstract][Full Text] [Related]
3. An upconverting nanotheranostic agent activated by hypoxia combined with NIR irradiation for selective hypoxia imaging and tumour therapy.
Li H; Lei W; Wu J; Li S; Zhou G; Liu D; Yang X; Wang S; Li Z; Zhang J
J Mater Chem B; 2018 May; 6(18):2747-2757. PubMed ID: 32254227
[TBL] [Abstract][Full Text] [Related]
4. A self-immolative prodrug nanosystem capable of releasing a drug and a NIR reporter for in vivo imaging and therapy.
Wang Z; Wu H; Liu P; Zeng F; Wu S
Biomaterials; 2017 Sep; 139():139-150. PubMed ID: 28614754
[TBL] [Abstract][Full Text] [Related]
5. [Antisense oligonucleotides with antitumor activity].
Otvös L; Sági G
Magy Onkol; 2004; 48(3):221-7. PubMed ID: 15520872
[TBL] [Abstract][Full Text] [Related]
6. A novel anticancer theranostic pro-prodrug based on hypoxia and photo sequential control.
Feng W; Gao C; Liu W; Ren H; Wang C; Ge K; Li S; Zhou G; Li H; Wang S; Jia G; Li Z; Zhang J
Chem Commun (Camb); 2016 Aug; 52(60):9434-7. PubMed ID: 27379361
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and biological evaluation of butanoate, retinoate, and bis(2,2,2-trichloroethyl)phosphate derivatives of 5-fluoro-2'-deoxyuridine and 2',5-difluoro-2'-deoxyuridine as potential dual action anticancer prodrugs.
Xia Z; Wiebe LI; Miller GG; Knaus EE
Arch Pharm (Weinheim); 1999 Aug; 332(8):286-94. PubMed ID: 10489539
[TBL] [Abstract][Full Text] [Related]
8. Noncovalent Theranostic Prodrug for Hypoxia-Activated Drug Delivery and Real-Time Tracking.
Zhao XB; Gao K; Shi YP
Anal Chem; 2021 Nov; 93(45):15080-15087. PubMed ID: 34743509
[TBL] [Abstract][Full Text] [Related]
9. A Glutathione (GSH)-Responsive Near-Infrared (NIR) Theranostic Prodrug for Cancer Therapy and Imaging.
Kong F; Liang Z; Luan D; Liu X; Xu K; Tang B
Anal Chem; 2016 Jun; 88(12):6450-6. PubMed ID: 27216623
[TBL] [Abstract][Full Text] [Related]
10. Targeting and Treatment of Tumor Hypoxia by Newly Designed Prodrug Possessing High Permeability in Solid Tumors.
Ikeda Y; Hisano H; Nishikawa Y; Nagasaki Y
Mol Pharm; 2016 Jul; 13(7):2283-9. PubMed ID: 27187083
[TBL] [Abstract][Full Text] [Related]
11. Self-Assembled Nanoparticles of Amphiphilic Twin Drug from Floxuridine and Bendamustine for Cancer Therapy.
Zhang T; Huang P; Shi L; Su Y; Zhou L; Zhu X; Yan D
Mol Pharm; 2015 Jul; 12(7):2328-36. PubMed ID: 25996874
[TBL] [Abstract][Full Text] [Related]
12. Floxuridine Oligomers Activated under Hypoxic Environment.
Morihiro K; Ishinabe T; Takatsu M; Osumi H; Osawa T; Okamoto A
J Am Chem Soc; 2021 Mar; 143(9):3340-3347. PubMed ID: 33648338
[TBL] [Abstract][Full Text] [Related]
13. Cytotoxicity of new duplex drugs linking 3'-C-ethynylcytidine and 5-fluor-2'-deoxyuridine against human melanoma cells.
Schott S; Niessner H; Sinnberg T; Venturelli S; Berger A; Ikenberg K; Villanueva J; Meier F; Garbe C; Busch C
Int J Cancer; 2012 Nov; 131(9):2165-74. PubMed ID: 22323315
[TBL] [Abstract][Full Text] [Related]
14. Hyaluronic acid-shelled acid-activatable paclitaxel prodrug micelles effectively target and treat CD44-overexpressing human breast tumor xenografts in vivo.
Zhong Y; Goltsche K; Cheng L; Xie F; Meng F; Deng C; Zhong Z; Haag R
Biomaterials; 2016 Apr; 84():250-261. PubMed ID: 26851390
[TBL] [Abstract][Full Text] [Related]
15. NIR Fluorogenic Dye as a Modular Platform for Prodrug Assembly: Real-Time in vivo Monitoring of Drug Release.
Redy-Keisar O; Ferber S; Satchi-Fainaro R; Shabat D
ChemMedChem; 2015 Jun; 10(6):999-1007. PubMed ID: 25847527
[TBL] [Abstract][Full Text] [Related]
16. Mitochondrial induced and self-monitored intrinsic apoptosis by antitumor theranostic prodrug: in vivo imaging and precise cancer treatment.
Kumar R; Han J; Lim HJ; Ren WX; Lim JY; Kim JH; Kim JS
J Am Chem Soc; 2014 Dec; 136(51):17836-43. PubMed ID: 25402959
[TBL] [Abstract][Full Text] [Related]
17. A DT-diaphorase responsive theranostic prodrug for diagnosis, drug release monitoring and therapy.
Liu P; Xu J; Yan D; Zhang P; Zeng F; Li B; Wu S
Chem Commun (Camb); 2015 Jun; 51(46):9567-70. PubMed ID: 25971544
[TBL] [Abstract][Full Text] [Related]
18. Human transport protein carrier for controlled photoactivation of antitumor prodrug and real-time intracellular tumor imaging.
Li X; Mu J; Liu F; Tan EW; Khezri B; Webster RD; Yeow EK; Xing B
Bioconjug Chem; 2015 May; 26(5):955-61. PubMed ID: 25938732
[TBL] [Abstract][Full Text] [Related]
19. Dual targeting of hypoxic and acidic tumor environments with a cobalt(III) chaperone complex.
Yamamoto N; Renfrew AK; Kim BJ; Bryce NS; Hambley TW
J Med Chem; 2012 Dec; 55(24):11013-21. PubMed ID: 23199008
[TBL] [Abstract][Full Text] [Related]
20. Anticancer drug released from near IR-activated prodrug overcomes spatiotemporal limits of singlet oxygen.
Rajaputra P; Bio M; Nkepang G; Thapa P; Woo S; You Y
Bioorg Med Chem; 2016 Apr; 24(7):1540-9. PubMed ID: 26928287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
